References
- SchwartzRNAnemia in patients with cancer: incidence, causes, impact, management, and use of treatment guidelines and protocolsAm J Health Syst Pharm2007643 Suppl 2S5S13 quiz S28–S3017244886
- RodgersGM3rdBeckerPSBlinderMCancer-and chemotherapy-induced anemiaJ Natl Compr Canc Netw201210562865322570293
- DicatoMPlawnyLDiederichMAnemia in cancerAnn Oncol201021Suppl 7vii167vii17220943610
- WuYAravindSRanganathanGMartinANalysnykLAnemia and thrombocytopenia in patients undergoing chemotherapy for solid tumors: a descriptive study of a large outpatient oncology practice database, 2000–2007Clin Ther200931Pt 22416243220110050
- GroopmanJEItriLMChemotherapy-induced anemia in adults: incidence and treatmentJ Natl Cancer Inst199991191616163410511589
- CapoGWaltzmanRManaging hematologic toxicitiesJ Support Oncol200421657915330374
- LudwigHVan BelleSBarrett-LeePThe European Cancer Anaemia Survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patientsEur J Cancer200440152293230615454256
- HarperPLittlewoodTAnaemia of cancer: impact on patient fatigue and long-term outcomeOncology200569Suppl 22716244504
- NieboerPBuijsCRodenhuisSFatigue and relating factors in high-risk breast cancer patients treated with adjuvant standard or high-dose chemotherapy: a longitudinal studyJ Clin Oncol200523338296830416219926
- CellaDKallichJMcDermottAXuXThe longitudinal relationship of hemoglobin, fatigue and quality of life in anemic cancer patients: results from five randomized clinical trialsAnn Oncol200415697998615151958
- Leyland-JonesBSemiglazovVPawlickiMMaintaining normal hemoglobin levels with epoetin α in mainly nonanemic patients with metastatic breast cancer receiving first-line chemotherapy: a survival studyJ Clin Oncol200523255960597216087945
- HenkeMLaszigRRubeCErythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trialLancet200336293921255126014575968
- SmithREJrAaproMSLudwigHDarbepoetin α for the treatment of anemia in patients with active cancer not receiving chemotherapy or radiotherapy: results of a phase III, multicenter, randomized, double-blind, placebo-controlled studyJ Clin Oncol20082671040105018227526
- WrightJRUngYCJulianJARandomized, double-blind, placebo-controlled trial of erythropoietin in non-small-cell lung cancer with disease-related anemiaJ Clin Oncol20072591027103217312332
- JunejaVKeeganPGootenbergJEContinuing reassessment of the risks of erythropoiesis-stimulating agents in patients with cancerClin Cancer Res200814113242324718519748
- XuHKayeJASaltusCWCrawfordJGasalEGoodnoughLTBlood utilization and hemoglobin levels in cancer patients after label and coverage changes for erythropoiesis-stimulating agentsExpert Rev Hematol20147561763325081548
- KoebnickCLanger-GouldAMGouldMKSociodemographic characteristics of members of a large, integrated health care system: comparison with US Census Bureau dataPerm J2012163374123012597
- SheminDRittenbergDThe life span of the human red blood cellJ Biol Chem1946166262763620276177